57
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Insulin-like Growth Factor-1 (IGF-1)-derived Peptide Protects against Diabetes in NOD Mice

, , , , , , , , & show all
Pages 481-487 | Received 22 Mar 2004, Accepted 14 Jul 2004, Published online: 07 Jul 2009

references

  • Kaufman, DL., Clare-Salzler, M., Tian, J., Forsthuber, T., Ting, G.S., Robinson, P., Atkinson, MA., Sercarz, E.E., Tobin, A.J. and Lehmann, P.V. (1993) "Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes", Nature 366(6450), 69–72.
  • Tisch, R., Yang, X.D., Singer, S.M., Liblau, R.S., Fugger, L. and McDevitt, HO. (1993) "Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice", Nature 366(6450), 72–75.
  • Atkinson, MA., Maclaren, N.K. and Luchetta, R. (1990) "Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy", Diabetes 39(8), 933–937.
  • Zhang, Z.J., Davidson, L., Eisenbarth, G. and Weiner, H.L. (1991) "Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin", Proc. Natl Acad. Sci. USA 88(22), 10252–10256.
  • Elias, D., Markovits, D., Reshef, T., van der Zee, R. and Cohen, I.R. (1990) "Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein", Proc. Natl Acad. Sci. USA 87(4), 1576–1580.
  • Elias, D., Reshef, T., Birk, 0.5., van der Zee, R., Walker, M.D. and Cohen, I.R. (1991) "Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein", Proc. Natl Acad. Sci. USA 88(8), 3088–3091.
  • Elias, D. and Cohen, I.R. (1994) "Peptide therapy for diabetes in NOD mice", Lancet 343(8899), 704–706.
  • Makin°, S., Kunimoto, K., Muraoka, Y, Mizushima, Y, Katagiri, K. and Tochino, Y. (1980) "Breeding of anon-obese, diabetic strain of mice", Jikken Dobutsu 29(1), 1–13.
  • Maruyama, T., Takei, I., Matsuba, I., Tsuruoka, A., Taniyama, M., Ikeda, Y, Kataoka, K., Abe, M. and Matsuld, S. (1984) "Cell-mediated cytotoxic islet cell surface antibodies to human pancreatic beta cells", Diabetologia 26(1), 30–33.
  • Shimada, A., Morimoto, J., Kodama, K., Suzuki, R., Oikawa, Y., Funae, 0., Kasuga, A., Saruta, T. and Narumi, S. (2001) "Elevated serum IP-10 levels observed in type 1 diabetes", Diabetes Care 24(3), 510–515.
  • Morris, T., Robertson, B. and Gallagher, M. (1996) "Rapid reverse transcription-PCR detection of hepatitis C virus RNA in serum by using the TaqMan fluorogenic detection system", J. Clin. Microbiol. 34(12), 2933–2936.
  • Urbanek-Ruiz, I., Ruiz, P.J., Paragas, V., Garren, H., Steinman, L. and Fathman, C.G. (2001) "Immunization with DNA encoding an immunodominant peptide of insulin prevents diabetes in NOD mice", Clin. Imnuinol. 100(2), 164–171.
  • Heath, V.L., Hutchings, P., Fowell, D.J., Cooke, A. and Mason, D.W. (1999) "Peptides derived from murine insulin are diabeto-genic in both rats and mice, but the disease-inducing epitopes are different: evidence against a common environmental cross-reactivity in the pathogenicity of type 1 diabetes", Diabetes 48(11), 2157–2165.
  • Hutchings, P. and Cooke, A. (1998) "Protection from insulin dependent diabetes mellitus afforded by insulin antigens in incomplete Freund's adjuvant depends on route of administration", Autoimmunity 11(2), 127–130.
  • Ramiya, V.K., Shang, X.Z., Pharis, P.G., Wasserfall, C.H., Stabler, TV., Muir, A.B., Schatz, D.A. and Maclaren, N.K. (1996) "Antigen based therapies to prevent diabetes in NOD mice", J. Autoimmun. 9(3), 349–356.
  • Daniel, D. and Wegmann, D.R. (1996) "Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23)", Proc. Nall Acad. Sci. USA 93(2), 956–960.
  • Kaino, Y, Hirai, H., Ito, T. and Kida, K. (1998) "Prevention of diabetes in non-obese diabetic (NOD) mice by short-term and high-dose IGF-I treatment", J. Pediatr. Endocrinol. Metab. 11(2), 267–272.
  • Kaino, Y, Hirai, H., Ito, T. and Kida, K. (1996) "Insulin-like growth factor I (IGF-I) delays the onset of diabetes in non-obese diabetic (NOD) mice", Diabetes Res. Clin. Pract. 34(1), 7–11.
  • Bergerot, I., Fabien, N., Maguer, V. and Thivole, C. (1995) "Insulin-like growth factor-1 (IGF-1) protects NOD mice from insulitis and diabetes", Clin. Exp. Immunol. 102(2), 335–340.
  • Quinn, A., McInerney, B., Reich, E.P., Kim, 0., Jensen, K.P. and Sercarz, E.E. (2001) "Regulatory and effector CD4 T cells in nonobese diabetic mice recognize overlapping determinants on glutamic acid decarboxylase and use distinct V beta genes", J. Immunol. 166(5), 2982–2991.
  • Sai, P., Rivereau, AS., Granier, C., Haertle, T. and Martignat, L. (1996) "Immunization of non-obese diabetic (NOD) mice with glutamic acid decarboxylase-derived peptide 524–543 reduces

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.